Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 29

1.

Gene gun immunization in a preclinical model is enhanced by B7 targeting.

Tachedjian M, Boyle JS, Lew AM, Horvatic B, Scheerlinck JP, Tennent JM, Andrew ME.

Vaccine. 2003 Jun 20;21(21-22):2900-5.

PMID:
12798633
2.

Molecular characterization of a secreted enzyme with phospholipase B activity from Moraxella bovis.

Farn JL, Strugnell RA, Hoyne PA, Michalski WP, Tennent JM.

J Bacteriol. 2001 Nov;183(22):6717-20.

3.

Local immune responses to influenza antigen are synergistically enhanced by the adjuvant ISCOMATRIX.

Windon RG, Chaplin PJ, McWaters P, Tavarnesi M, Tzatzaris M, Kimpton WG, Cahill RN, Beezum L, Coulter A, Drane D, Sjölander A, Pearse M, Scheerlinck JP, Tennent JM.

Vaccine. 2001 Nov 12;20(3-4):490-7.

PMID:
11672914
4.

The immune response to a DNA vaccine can be modulated by co-delivery of cytokine genes using a DNA prime-protein boost strategy.

Scheerlinck JP, Casey G, McWaters P, Kelly J, Woollard D, Lightowlers MW, Tennent JM, Chaplin PJ.

Vaccine. 2001 Jul 16;19(28-29):4053-60.

PMID:
11427282
5.

Induction of lymphocyte recruitment in the absence of a detectable immune response.

Windon RG, Chaplin PJ, Beezum L, Coulter A, Cahill R, Kimpton W, Drane D, Pearse M, Sjölander A, Tennent JM, Scheerlinck JY.

Vaccine. 2000 Oct 15;19(4-5):572-8.

PMID:
11027823
6.

Identification of type 4 fimbriae in Actinobacillus pleuropneumoniae.

Zhang Y, Tennent JM, Ingham A, Beddome G, Prideaux C, Michalski WP.

FEMS Microbiol Lett. 2000 Aug 1;189(1):15-8.

7.

Ovine interleukin-12: analysis of biologic function and species comparison.

De Rose R, Scheerlinck JP, Casey G, Wood PR, Tennent JM, Chaplin PJ.

J Interferon Cytokine Res. 2000 Jun;20(6):557-64.

PMID:
10888112
8.

Characterization of hemolysin of Moraxella bovis using a hemolysis-neutralizing monoclonal antibody.

Billson FM, Harbour C, Michalski WP, Tennent JM, Egerton JR, Hodgson JL.

Infect Immun. 2000 Jun;68(6):3469-74.

9.

Targeting improves the efficacy of a DNA vaccine against Corynebacterium pseudotuberculosis in sheep.

Chaplin PJ, De Rose R, Boyle JS, McWaters P, Kelly J, Tennent JM, Lew AM, Scheerlinck JP.

Infect Immun. 1999 Dec;67(12):6434-8.

10.

Identification, purification, and characterization of the type 4 fimbriae of Pasteurella multocida.

Ruffolo CG, Tennent JM, Michalski WP, Adler B.

Infect Immun. 1997 Jan;65(1):339-43.

11.
12.

A haemolytic cell-free preparation of Moraxella bovis confers protection against infectious bovine keratoconjunctivitis.

Billson FM, Hodgson JL, Egerton JR, Lepper AW, Michalski WP, Schwartzkoff CL, Lehrbach PR, Tennent JM.

FEMS Microbiol Lett. 1994 Nov 15;124(1):69-73.

PMID:
8001772
13.

Characterization of pilin genes from seven serologically defined prototype strains of Moraxella bovis.

Atwell JL, Tennent JM, Lepper AW, Elleman TC.

J Bacteriol. 1994 Aug;176(16):4875-82.

14.

Multidrug resistance to antiseptics and disinfectants in coagulase-negative staphylococci.

Leelaporn A, Paulsen IT, Tennent JM, Littlejohn TG, Skurray RA.

J Med Microbiol. 1994 Mar;40(3):214-20.

PMID:
8114073
15.

A Moraxella bovis pili vaccine produced by recombinant DNA technology for the prevention of infectious bovine keratoconjunctivitis.

Lepper AW, Elleman TC, Hoyne PA, Lehrbach PR, Atwell JL, Schwartzkoff CL, Egerton JR, Tennent JM.

Vet Microbiol. 1993 Jul;36(1-2):175-83.

PMID:
7901935
16.
17.

Substrate specificity and energetics of antiseptic and disinfectant resistance in Staphylococcus aureus.

Littlejohn TG, Paulsen IT, Gillespie MT, Tennent JM, Midgley M, Jones IG, Purewal AS, Skurray RA.

FEMS Microbiol Lett. 1992 Aug 15;74(2-3):259-65.

PMID:
1526458
18.

Horizontal gene transfer of the Escherichia coli pap and prs pili operons as a mechanism for the development of tissue-specific adhesive properties.

Marklund BI, Tennent JM, Garcia E, Hamers A, Båga M, Lindberg F, Gaastra W, Normark S.

Mol Microbiol. 1992 Aug;6(16):2225-42.

PMID:
1357526
19.

Integrity of Escherichia coli P pili during biogenesis: properties and role of PapJ.

Tennent JM, Lindberg F, Normark S.

Mol Microbiol. 1990 May;4(5):747-58.

PMID:
1975085
20.

PapD, a periplasmic transport protein in P-pilus biogenesis.

Lindberg F, Tennent JM, Hultgren SJ, Lund B, Normark S.

J Bacteriol. 1989 Nov;171(11):6052-8.

21.

The PapG adhesin of uropathogenic Escherichia coli contains separate regions for receptor binding and for the incorporation into the pilus.

Hultgren SJ, Lindberg F, Magnusson G, Kihlberg J, Tennent JM, Normark S.

Proc Natl Acad Sci U S A. 1989 Jun;86(12):4357-61.

22.

Physical and biochemical characterization of the qacA gene encoding antiseptic and disinfectant resistance in Staphylococcus aureus.

Tennent JM, Lyon BR, Midgley M, Jones IG, Purewal AS, Skurray RA.

J Gen Microbiol. 1989 Jan;135(1):1-10.

PMID:
2778425
23.

Preliminary X-ray study of papD crystals from uropathogenic Escherichia coli.

Holmgren A, Brändén CI, Lindberg F, Tennent JM.

J Mol Biol. 1988 Sep 5;203(1):279-80.

PMID:
2903252
24.
25.

Multiresistant Staphylococcus aureus: genetics and evolution of epidemic Australian strains.

Skurray RA, Rouch DA, Lyon BR, Gillespie MT, Tennent JM, Byrne ME, Messerotti LJ, May JW.

J Antimicrob Chemother. 1988 Apr;21 Suppl C:19-39. Review.

PMID:
2838448
27.
28.

Cloning and expression of Staphylococcus aureus plasmid-mediated quaternary ammonium resistance in Escherichia coli.

Tennent JM, Lyon BR, Gillespie MT, May JW, Skurray RA.

Antimicrob Agents Chemother. 1985 Jan;27(1):79-83.

Supplemental Content

Loading ...
Support Center